ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2099

Genome-Wide Association Study of Clinically-Defined Gout Identifies Multiple Risk Loci: A Clue for Future Companion Diagnostics of Gout

Hirotaka Matsuo1, Ken Yamamoto2, Hirofumi Nakaoka3, Akiyoshi Nakayama1, Masayuki Sakiyama1, Atsushi Takahashi4,5, Takahiro Nakamura6, Yusuke Kawamura1, Nobuyuki Hamajima7, Ituro Inoue8, Michiaki Kubo4, Kimiyoshi Ichida9, Hiroshi Ooyama10, Toru Shimizu11 and Nariyoshi Shinomiya1, 1Department of Integrative Physiology and Bio-Nano Medicine, National Defense Medical College, Tokorozawa, Japan, 2Department of Medical Chemistry, Kurume University School of Medicine, Kurume, Japan, 3Division of Human Genetics, Department of Integrated Genetics, National Institute of Genetics, Mishima, Japan, 4Center for Integrative Medical Sciences, RIKEN, Yokohama, Japan, 5Research Center, National Cerebral and Cardiovascular Center, Suita, Japan, 6National Defense Medical College, Laboratory for Mathematics, Tokorozawa, Japan, 7Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya, Japan, 8Department of Integrated Genetics, National Institute of Genetics, Mishima, Japan, 9Department of Pathophysiology, Tokyo University of Pharmacy and Life Sciences, Hachioji, Japan, 10Ryougoku East Gate Clinic, Tokyo, Japan, 11Midorigaoka Hospital, Takatsuki, Japan

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: gout, GWAS, Pathophysiology, polymorphism and uric acid

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 9, 2015

Title: Genetics, Genomics and Proteomics

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Gout, caused by hyperuricaemia, is a multifactorial disease. Recently, genome-wide association studies (GWASs) of gout have been reported; however, they included self-reported gout cases. Therefore, the relationship between genetic variation and clinical subtypes of gout remains to be clarified. We hereby first performed a GWAS of clinically-defined gout cases only.

Methods: A GWAS was conducted with 945 clinically-defined gout cases and 1,213 controls in a Japanese male population. Additionally, a replication study of 1,048 clinically-defined cases and 1,334 controls was performed.

Results: We identified five susceptibility loci for gout at the genome-wide significance level (p≺ 5.0 × 10-8, which contained well-known urate transporter genes (ABCG2 and SLC2A9) and additional genes reported to have relationships with metabolic pathways: rs1260326 (p = 1.9 × 10-12; OR = 1.36) of GCKR (a gene for glucose and lipid metabolism), rs2188380 (p = 1.6 × 10-23; OR = 1.75) of MYL2-CUX2 (genes associated with cholesterol and diabetes mellitus), and rs4073582 (p = 6.4 × 10-9; OR = 1.66) of CNIH-2 (a gene for regulation of glutamate signaling). The latter two are identified as novel loci for gout. Furthermore, we demonstrated that the identified SNPs were differentially associated with types of gout and clinical parameters underlying specific subtypes. The effect of the risk allele of each SNP on clinical parameters showed significant linear relationships with the ratio of the case-control ORs for two distinct types of gout (r = 0.96 [p = 4.8 × 10-4] for urate clearance and r = 0.96 [p = 5.0 × 10-4] for urinary urate excretion).

Conclusion: Our findings provide clues to better understand the pathogenesis of gout and will be useful to develop companion diagnostics of gout.


Disclosure: H. Matsuo, a patent, 9; K. Yamamoto, None; H. Nakaoka, None; A. Nakayama, None; M. Sakiyama, None; A. Takahashi, None; T. Nakamura, None; Y. Kawamura, None; N. Hamajima, None; I. Inoue, None; M. Kubo, None; K. Ichida, None; H. Ooyama, None; T. Shimizu, None; N. Shinomiya, a patent, 9.

To cite this abstract in AMA style:

Matsuo H, Yamamoto K, Nakaoka H, Nakayama A, Sakiyama M, Takahashi A, Nakamura T, Kawamura Y, Hamajima N, Inoue I, Kubo M, Ichida K, Ooyama H, Shimizu T, Shinomiya N. Genome-Wide Association Study of Clinically-Defined Gout Identifies Multiple Risk Loci: A Clue for Future Companion Diagnostics of Gout [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/genome-wide-association-study-of-clinically-defined-gout-identifies-multiple-risk-loci-a-clue-for-future-companion-diagnostics-of-gout/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/genome-wide-association-study-of-clinically-defined-gout-identifies-multiple-risk-loci-a-clue-for-future-companion-diagnostics-of-gout/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology